Myosteatosis in NAFLD patients correlates with plasma Cathepsin D
Previously, we have shown that hepatic lipid accumulation induces the secretion of cathepsin D (CTSD), and that plasma CTSD levels are associated with increased inflammation and disease severity in nonalcoholic fatty liver disease (NAFLD). Although it is clear that the liver is a major source of pla...
Main Authors: | Ding Lingling, De Munck Toon. J. I., Oligschlaeger Yvonne, dos Reis Inês Magro, Verbeek Jef, Koek Ger. H., Houben Tom, Shiri-Sverdlov Ronit |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2021-05-01
|
Series: | Biomolecular Concepts |
Subjects: | |
Online Access: | https://doi.org/10.1515/bmc-2021-0004 |
Similar Items
-
Insulin resistance is positively associated with plasma cathepsin D activity in NAFLD patients
by: Ding Lingling, et al.
Published: (2021-08-01) -
Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models
by: Maxime Nachit, et al.
Published: (2021-02-01) -
NAFLD Preclinical Models: More than a Handful, Less of a Concern?
by: Yvonne Oligschlaeger, et al.
Published: (2020-02-01) -
Cathepsin D inhibitors
by: M. Gacko, et al.
Published: (2007-11-01) -
Characterizing cancer‐associated myosteatosis: anatomic distribution and cancer‐specific variability of low radiodensity muscle
by: Victoria Armstrong, et al.
Published: (2021-07-01)